Investor Tips New vaccine entrant gets approval before Novavax, while herd immunity ideas put sales in doubt. Articles You May Like Five Below (FIVE) and Campbell’s (CPB): 4/28/26 Bull & Bear Dow (DOW) and Louisana-Pacific (LPX): 5/1/26 Bull & Bear Bloom Energy Surges After EPS Beat and AI Demand What Stocks to Watch on the Craziest Day in Earnings History